RLAY
RLAY
NASDAQ · Biotechnology

Relay Therapeutics Inc

$19.77
+0.02 (+0.10%)
As of Aug 8, 10:08 PM ET ·
Analyst Consensus
Strong Buy
18
Analysts
High
Coverage
Buy 17 94%
Hold 1 6%
Sell 0 0%
Price Target
Analyst Price Target +229.9% upside
Low Target $47.67
Average Target $65.23
High Target $99.61
Current Price $19.77
Current
$19.77
Target
$65.23
$47.67 $65.23 avg $99.61
Scenario Analysis
Bear Case
$47.67
141.1%
Low target
Base Case
$65.23
+229.9%
Avg target
Bull Case
$99.61
+403.8%
High target
Risk/Reward
2.9x
Favorable
Price in Context
52-Week High
$20.79
-4.9% from high
52-Week Low
$3.03
+553.6% from low
Target vs 52W High
$65.23
+213.8% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 39 79% $257.58 +4.7%
AMGN
Amgen Inc
Hold 43 49% $190.87 -53.6%
GILD
Gilead Sciences Inc
Strong Buy 37 81% $362.68 +172.3%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 40 83% $438.34 -11.6%
REGN
Regeneron Pharmaceuticals
Buy 38 71% $76.80 -90.2%
NTRA
Natera Inc
Strong Buy 30 87% $142.91 -55.6%
RVMD
Revolution Medicines Inc
Strong Buy 29 93% $114.11 -44.4%
BIIB
Biogen Inc
Buy 44 64% $91.45 -56.0%